ECSP067049A - Revestimientos de azucar y metodos para estos - Google Patents

Revestimientos de azucar y metodos para estos

Info

Publication number
ECSP067049A
ECSP067049A EC2006007049A ECSP067049A ECSP067049A EC SP067049 A ECSP067049 A EC SP067049A EC 2006007049 A EC2006007049 A EC 2006007049A EC SP067049 A ECSP067049 A EC SP067049A EC SP067049 A ECSP067049 A EC SP067049A
Authority
EC
Ecuador
Prior art keywords
coatings
methods
compositions
solid dose
dose forms
Prior art date
Application number
EC2006007049A
Other languages
English (en)
Inventor
John C Clark
John J Michelucci
Deborah Marie Sherman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP067049A publication Critical patent/ECSP067049A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proveen las composiciones particularmente útiles como revestimientos para formas de dosis en sólidos de agentes terapéuticos, que se encuentran como formas de dosis en sólidos que comprenden dichos revestimientos, procedimientos para la preparación de dichas formas de dosis en sólidos, y los productos de esos procedimientos; las composiciones para revestimiento generalmente proveen una excelente fuerza y resistencia a la fragmentación, incluso cuando se aplica a núcleos de tableta flexibles/que se pueden hinchar tales como núcleos tipo hidrogel; las composiciones también exhiben excelentes características de bloqueo de olor.
EC2006007049A 2004-06-07 2006-12-07 Revestimientos de azucar y metodos para estos ECSP067049A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57766804P 2004-06-07 2004-06-07

Publications (1)

Publication Number Publication Date
ECSP067049A true ECSP067049A (es) 2007-02-28

Family

ID=35351681

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006007049A ECSP067049A (es) 2004-06-07 2006-12-07 Revestimientos de azucar y metodos para estos

Country Status (23)

Country Link
US (2) US20050271724A1 (es)
EP (1) EP1753407B1 (es)
JP (1) JP5000509B2 (es)
CN (1) CN101267809A (es)
AR (1) AR049142A1 (es)
AU (1) AU2005251793B2 (es)
BR (1) BRPI0511663A (es)
CA (1) CA2566771A1 (es)
CR (1) CR8778A (es)
EC (1) ECSP067049A (es)
ES (1) ES2623363T3 (es)
GT (1) GT200500141A (es)
IL (1) IL179537A0 (es)
MX (1) MXPA06014229A (es)
NO (1) NO20070091L (es)
NZ (1) NZ551676A (es)
PA (1) PA8636001A1 (es)
PE (1) PE20060245A1 (es)
RU (1) RU2428178C2 (es)
SV (1) SV2006002136A (es)
TW (1) TW200602089A (es)
UA (1) UA86413C2 (es)
WO (1) WO2005120466A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
WO2008013084A1 (fr) * 2006-07-25 2008-01-31 Kowa Company, Ltd. Préparation enrobée de sucre et son procédé de fabrication
WO2008067387A2 (en) * 2006-11-29 2008-06-05 Wyeth Estrogen/ serm and estrogen/ progestin bi-layer tablets
BRPI0806543A2 (pt) * 2007-01-12 2014-04-22 Wyeth Corp Composições de comprimido em comprimido
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2009135067A1 (en) * 2008-05-01 2009-11-05 Wyeth Pharmaceutical polish formulations
WO2009158584A1 (en) * 2008-06-27 2009-12-30 Wyeth Dual adhesive technology
CN101744725B (zh) * 2008-12-09 2013-04-17 北京华素制药股份有限公司 缓释微丸包衣生产工艺参数的优化方法
WO2010075080A1 (en) * 2008-12-15 2010-07-01 Somnus Therapeutics, Inc. A method of treating insomnia
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US20110052687A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Extended release pharmaceutical composition of paliperidone
EP2477614A2 (en) * 2009-09-17 2012-07-25 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8663671B2 (en) * 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
SG183993A1 (en) * 2010-03-09 2012-10-30 Alkermes Pharma Ireland Ltd Alcohol resistant enteric pharmaceutical compositions
EP2568973A2 (en) 2010-05-11 2013-03-20 Sensient Colors LLC Film coating composition and methods of making and using the same
RU2013135224A (ru) * 2011-01-20 2015-03-10 Бионевиа Фармасьютикалс Инк. Композиции с модифицированным высвобождением эпалрестата или его производных и способы их использования
US8846089B2 (en) * 2011-06-03 2014-09-30 Wakunaga Pharmaceutical Co., Ltd. Sugar-coated preparation and production method for the same
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
JP6504163B2 (ja) * 2014-06-02 2019-04-24 ニプロ株式会社 レーザー印刷用錠剤及びその製造方法
WO2016108250A1 (en) 2015-01-01 2016-07-07 Ideal Cures Pvt. Ltd. Novel film coating composition
US20180000742A1 (en) * 2015-01-29 2018-01-04 Novo Nordisk A/S Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
RU2753049C2 (ru) * 2016-08-04 2021-08-11 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи Легкие для глотания покрытия и покрытые ими субстраты
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
MX2019008440A (es) * 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
US5210081A (en) 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
WO1995006462A1 (en) * 1993-08-30 1995-03-09 Warner-Lambert Company Tablet coating based on a melt-spun mixture of a saccharide and apolymer
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
PL360916A1 (en) * 1999-03-29 2004-09-20 Wyeth Coating system
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
WO2003075918A1 (fr) * 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie humide)

Also Published As

Publication number Publication date
IL179537A0 (en) 2007-05-15
MXPA06014229A (es) 2007-05-04
CR8778A (es) 2007-10-01
AU2005251793A1 (en) 2005-12-22
EP1753407B1 (en) 2017-03-08
PA8636001A1 (es) 2006-05-16
CN101267809A (zh) 2008-09-17
AU2005251793B2 (en) 2010-07-15
RU2006140093A (ru) 2008-07-20
JP5000509B2 (ja) 2012-08-15
NO20070091L (no) 2007-01-05
AR049142A1 (es) 2006-06-28
US20110136772A1 (en) 2011-06-09
US20050271724A1 (en) 2005-12-08
BRPI0511663A (pt) 2008-01-02
CA2566771A1 (en) 2005-12-22
RU2428178C2 (ru) 2011-09-10
PE20060245A1 (es) 2006-05-03
SV2006002136A (es) 2006-02-15
JP2008501803A (ja) 2008-01-24
ES2623363T3 (es) 2017-07-11
NZ551676A (en) 2010-11-26
WO2005120466A2 (en) 2005-12-22
EP1753407A2 (en) 2007-02-21
UA86413C2 (ru) 2009-04-27
WO2005120466A3 (en) 2007-04-19
TW200602089A (en) 2006-01-16
GT200500141A (es) 2006-01-10

Similar Documents

Publication Publication Date Title
ECSP067049A (es) Revestimientos de azucar y metodos para estos
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
UY31747A (es) Nuevas formulaciones, comprimidos que comprenden tales formulaciones, su uso y procedimiento para su preparacion
CR8767A (es) Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso
CR9022A (es) Derivados de sulfonamida novedosos como moduladores de receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
AR080912A1 (es) Formas de dosificacion solidas orales con dosis muy bajas para la hrt
CR20110599A (es) Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
WO2012154679A8 (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same
AR081774A1 (es) Composiciones farmaceuticas de co-cristales de tramadol y coxibs
UY30304A1 (es) Moduladores de mglur5 i
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
BR112014017780A8 (pt) Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos
ECSP077323A (es) Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
UY30307A1 (es) Moduladores de mglur5 vi
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
CL2007002919A1 (es) Compuestos derivados de pirido[2,3-b]indol, inhibidores de quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar cancer, entre otras enfermedades.
CL2007003251A1 (es) Compuestos derivados de 1h-pirazoles sustituidos, inhibidores de reacciones catalizadas por una quinasa; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; uso de los compuestos principales, utiles en el tratamiento del cancer.
PA8654701A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
BRPI0719885B8 (pt) peptídeos peguilados como moduladores de receptores de pth, seus usos, e composição.
CL2008001325A1 (es) Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades.